Elisabeth R. van Wering

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

Jacques J. M. van Dongen, Taku Seriu, E. Renate Panzer-Grümayer et al. · The Lancet · 1998 · 956 citations

Hematological Malignancy, Lymphoid Neoplasia, Acute Lymphoblastic Leukaemia +9

Fetal origins of the <i>TEL-AML1</i> fusion gene in identical twins with leukemia

Anthony M. Ford, Caroline Bennett, Cathy M. Price et al. · Proceedings of the National Academy of Sciences · 1998 · 315 citations · Full text

In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

Gertjan J.L. Kaspers, A. Veerman, Rob Pieters et al. · Blood · 1997 · 270 citations · Full text

Protracted and Variable Latency of Acute Lymphoblastic Leukemia AfterTEL-AML1 Gene Fusion In Utero

Joseph L. Wiemels, Anthony M. Ford, Elisabeth R. van Wering et al. · Blood · 1999 · 257 citations

Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)

A. Veerman, Willem A. Kamps, Henk van den Berg et al. · The Lancet Oncology · 2009 · 247 citations

Hematological Malignancy, Protocol All-9, Lymphoid Neoplasia +8